Login to Pancreatic Cancer UK

Scientific Advisory Board

Pancreatic Cancer UK has a Scientific Advisory Board (SAB) with a strong international membership to ensure that funds raised will be spent as effectively as possible.

SAB Chair:

  • Professor Stephen Smith, International Academic and Health Consultancy (previously Dean of the Faculty of Medicine Dentistry and Health Sciences at the University of Melbourne and Chair Melbourne Health Academic Centre)

SAB Vice Chair:

  • Professor James Abbruzzese, Chief of the Division of Medical Oncology and Associate Director for Clinical Research for the Duke Cancer Institute (DCI), Waun Ki Hong Distinguished Chair in Translational Oncology

A number of distinguished international experts in the field also serve as members of the Board:

  • Professor Jim Abbruzzese, Chief of the Division of Medical Oncology and Associate Director for Clinical Research, Duke University, North Carolina, USA
  • Professor Andrew Biankin, Regius Chair of Surgery/Director of Translational Research Centre, Wolfson Wohl Cancer Research Centre, University of Glasgow, UK
  • Professor Carl Borrebaeck, Professor at Department of Immunotechnology, Lund University, Sweden
  • Professor Eithne Costello, Pancreas Research Group, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, UK
  • Professor Rajesh Chopra, Head of the Division of Cancer Therapeutics and Director of the Cancer Research UK Cancer Therapeutics Unit, Institute of Cancer Research, London
  • Professor Douglas Fearon, Professor, Cold Spring Harbor Laboratory, USA and University of Cambridge, UK
  • Professor Helmut Friess, Department of Surgery, Technische Universität München, Germany
  • Dr Julie Guillemert-Guibert, INSERM, Toulouse, France
  • Professor Kenneth Hess, Professor of Biostatistics, MD Andersor Cancer Centre, Texas USA
  • Professor Tony Hollingsworth, Associate Director for Basic Research, University of Nebraska, USA
  • Dr Raghu Kalluri, Professor and Chair, MD Anderson Cancer Centre, Texas USA
  • Professor Nick Lemoine, Director of the Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, University of London, UK
  • Professor Gillies McKenna, Head of the Department of Oncology, University of Oxford, UK
  • Professor Francisco Real, Programa de Patología Molecular, Centro Nacional de Investigaciones Oncológicas, Madrid, Spain
  • Dr Ilse Rooman, Vrije Universiteit, Belguim
  • Professor Margaret Tempero, Professor of Medicine, Division of Hematology and Oncology, University of California, San Francisco
  • Professor Juan Valle, Professor in Medical Oncology, University of Manchester, UK

SAB lay members: 

  • Roy Bowdery
  • Dr Anna Gerring
  • Michael Stead

As part of the scientific review process, the Board provides expert advice to the CEO and Trustees on:

  • Development of the charity's research strategy and grant giving programme
  • External referees for applications ('peer reviewers')
  • Assessment of and final recommendations on applications

The SAB also provides advice and support for the charity on reporting and dissemination of research results.

Conflicts of Interest Policy

Pancreatic Cancer UK has a rigorous policy on conflicts of interest in relation to both external peer reviewers and members of the SAB. Note that an important part of this policy is that the Chair or Vice Chair will withdraw from the entire research grants round if it includes any applications from members of his own research team.